These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34071063)

  • 1. Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy.
    Hale JE; Darras BT; Swoboda KJ; Estrella E; Chen JYH; Abbott MA; Hay BN; Kumar B; Counihan AM; Gerstel-Thompson J; Sahai I; Eaton RB; Comeau AM
    Int J Neonatal Screen; 2021 May; 7(2):. PubMed ID: 34071063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Modification of a Confirmatory SMA Sequencing Assay that Can Be Used to Determine
    Kumar B; Barton S; Kordowska J; Eaton RB; Counihan AM; Hale JE; Comeau AM
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
    Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
    Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
    Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
    J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. California's experience with SMA newborn screening: A successful path to early intervention.
    Matteson J; Wu CH; Mathur D; Tang H; Sciortino S; Feuchtbaum L; Bishop T; Sharma SC; Neogi P; Fitzgibbon I; Olney RS
    J Neuromuscul Dis; 2022; 9(6):777-785. PubMed ID: 36278357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project.
    Niri F; Nicholls J; Baptista Wyatt K; Walker C; Price T; Kelln R; Hume S; Parboosingh J; Lilley M; Kolski H; Ridsdale R; Muranyi A; Mah JK; Bulman DE
    Int J Neonatal Screen; 2023 Jul; 9(3):. PubMed ID: 37606479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening Assay.
    Adams SP; Gravett E; Kent N; Kricke S; Ifederu A; Scoto M; Samsuddin S; Muntoni F
    Int J Neonatal Screen; 2021 Oct; 7(4):. PubMed ID: 34842601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check.
    Kucera KS; Taylor JL; Robles VR; Clinard K; Migliore B; Boyea BL; Okoniewski KC; Duparc M; Rehder CW; Shone SM; Fan Z; Raspa M; Peay HL; Wheeler AC; Powell CM; Bailey DB; Gehtland LM
    Int J Neonatal Screen; 2021 Mar; 7(1):. PubMed ID: 33801060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
    Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
    Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 Years.
    Lee BH; Deng S; Chiriboga CA; Kay DM; Irumudomon O; Laureta E; Delfiner L; Treidler SO; Anziska Y; Sakonju A; Kois C; Farooq O; Engelstad K; Laurenzano A; Hogan K; Caggana M; Saavedra-Matiz CA; Stevens CF; Ciafaloni E
    Neurology; 2022 Oct; 99(14):e1527-e1537. PubMed ID: 35835557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan.
    Kimizu T; Ida S; Okamoto K; Awano H; Niba ETE; Wijaya YOS; Okazaki S; Shimomura H; Lee T; Tominaga K; Nabatame S; Saito T; Hamazaki T; Sakai N; Saito K; Shintaku H; Nozu K; Takeshima Y; Iijima K; Nishio H; Shinohara M
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing.
    Shum BOV; Henner I; Cairns A; Pretorius C; Wilgen U; Barahona P; Ungerer JPJ; Bennett G
    Front Genet; 2023; 14():1095600. PubMed ID: 36713073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Muscular Atrophy: New Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E44-E48. PubMed ID: 31956255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
    Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry.
    Lin Y; Lin CH; Yin X; Zhu L; Yang J; Shen Y; Yang C; Chen X; Hu H; Ma Q; Shi X; Shen Y; Hu Z; Huang C; Huang X
    Front Genet; 2019; 10():1255. PubMed ID: 31921298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.